BTLA Protein (Fc Tag)
-
- Target Alle BTLA Proteine anzeigen
- BTLA (B and T Lymphocyte Associated (BTLA))
- Protein-Typ
- Recombinant
-
Spezies
- Human
-
Quelle
- HEK-293 Cells
- Aufreinigungstag / Konjugat
- Dieses BTLA Protein ist gelabelt mit Fc Tag.
- Applikation
- Western Blotting (WB)
- Produktmerkmale
-
Fusion tag: C-Fc Tag
- Reinheit
- >90 % as determined by SDS-PAGE.
- Top Product
- Discover our top product BTLA Protein
-
-
- Applikationshinweise
- This recombinant protein can be used for WB. For research use only.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Buffer
- 50 mM tris, 100 mM glycine, pH 7.5
- Lagerung
- -80 °C,-20 °C
- Informationen zur Lagerung
- Lyophilized Protein should be stored at -20°C or lower for long term storage. Upon reconstitution, working aliquots should be stored at -20°C or -70°C. Avoid repeated freeze-thaw cycles.
-
- Target
- BTLA (B and T Lymphocyte Associated (BTLA))
- Andere Bezeichnung
- BTLA (BTLA Produkte)
- Synonyme
- BTLA Protein, BTLA1 Protein, CD272 Protein, A630002H24 Protein, B and T lymphocyte associated Protein, BTLA Protein, Btla Protein
- Hintergrund
- B- and T-lymphocyte attenuator (BTLA) is also known as B- and T-lymphocyte-associated protein, CD antigen CD272. BTLA contains one Ig-like V-type (immunoglobulin-like) domain. As a lymphocyte inhibitory receptor, BTLA / CD272 inhibits lymphocytes during immune response. BTLA / CD272 can interact with tyrosine phosphatases PTPN6/SHP-1 and PTPN11/SHP-2, and interact with TNFRSF14/HVEM.
- Molekulargewicht
- 38.7 kDa
- Gen-ID
- 151888
- NCBI Accession
- NP_001078826
- UniProt
- Q7Z6A9
- Pathways
- Cancer Immune Checkpoints
-